Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

19

Revenue 2017

Celgene

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Celgene's 2013 oncology sales performance.

Celgene

Sanofi signs $1bn licence agreement for Eureka’s novel multiple myeloma drug

Sanofi signs $1bn licence agreement for Eureka’s novel multiple myeloma drug

The FDA approved Sarclisa for the treatment of patients with relapsed or refractor multiple myeloma who have received at least two prior therapies, including Celgene’s Revlimid (lenalidomide) and a proteasome

BMS’s oral AML therapy Onureg receives EU approval

BMS’s oral AML therapy Onureg receives EU approval Onureg is the oral version of Vidaza, two of the drugs BMS gained as part of its acquisition of Celgene in 2019. ... Onureg is the oral version of Vidaza, two of the drugs BMS gained as part of its acquisition of Celgene for $74bn in 2019.

BMS links up with Exscientia for $1.2bn AI drug discovery deal

BMS links up with Exscientia for $1.2bn AI drug discovery deal The new deal builds on BMS’ existing collaboration with Exscientia, initiated in 2019 with Celgene prior to the company’s acquisition by BMS.

Building meaningful customer engagement through data-driven digital insights

Building meaningful customer engagement through data-driven digital insights An example of successful digital engagement can be seen in Celgene’s initiative to launch a hashtag, #PancChat, together with patient advocacy group Let’s Win!

FDA approves BMS’ blood cancer CAR T therapy after delay

FDA approves BMS’ blood cancer CAR T therapy after delay BMS acquired Breyanzi following its $74bn takeover of Celgene in 2019 – the CAR-T therapy is one of the key assets critical to the potential payout of the merger in contingent ... As part of the merger agreement, BMS agreed to make a series of

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...